COVID-19 pandemic represents an opportunity to refine existing models of health care delivery.
Updated: Oct 26, 2020
At Peripal we came up with a new business approach as a direct response to the current pandemic situation.
Something surely under consideration by many companies in these challenging times. We hope it is helpful to share our experiences with you and would be interested to hear back from you about how your company is adjusting to these times.
COVID-19 pandemic represents an opportunity to refine existing models of health care delivery At Peripal we came up with a new business approach as a direct response to the current pandemic situation. Something surely under consideration by many companies in these challenging times. We hope it is helpful to share our experiences with you and would be interested to hear back from you about how your company is adjusting to these times.
Why we do what we do
Peripal AG is a privately funded start-up from the ETH Zürich and MedTech industry experts. The company is active in the area of home dialysis. Its first product PeriSafe® guides the catheter connection without manual contact of the dialysis tubing. The device enables more patients to receive their dialysis therapy at home. Compared to hospital-based treatment, this would result in considerable healthcare cost reductions worldwide.
Read this article on LinkedIn or download below:
https://www.linkedin.com/feed/update/urn:li:activity:6719603361097760768
#healthcare #dialysis #homecare #covid #patient #medical #patientcare #hospitals #dialyse #nephrology #dialysis #endstagekidneydisease #chronickidneydisease #kidneydialysis #femaleempowerment #peritonealdialysis #peripal #perisafe